Irving Lara | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Dr. Irving Lara | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Research assistant at Centro de Investigación Biomédica de Occidente, Mexico

Dr. Irving Jair Lara Navarro is a Mexican researcher specializing in genetics and molecular biology. Born on December 9, 1990, in Guadalajara, Jalisco, he has dedicated his career to advancing genetic research, particularly in gene therapy. His work integrates molecular diagnostics, biotechnology, and clinical applications, making significant contributions to biomedical sciences. With a passion for teaching and research, he has been actively involved in academia and laboratory settings, working to bridge the gap between fundamental genetics and medical applications. Dr. Lara Navarro has played a key role in developing innovative approaches for genetic modification, particularly using CRISPR/Cas9 technology. His expertise extends to epidemiological surveillance, laboratory diagnostics, and academic instruction. Throughout his career, he has collaborated with various research institutions, healthcare professionals, and academic institutions, fostering a multidisciplinary approach to genetics. His commitment to scientific excellence and education continues to drive his contributions to the field.

Professional Profile

Education

Dr. Irving Jair Lara Navarro pursued his academic journey in biological sciences, earning a Bachelor’s degree in Biology from the University of Guadalajara (CUCBA) in 2014. His undergraduate research focused on optimizing transduction conditions in keratinocytes using lentiviral vectors. Continuing his passion for genetics, he pursued a Doctorate in Human Genetics at the University of Guadalajara (CUCS), completing it in 2024. His doctoral research revolved around gene therapy using CRISPR/Cas9 technology for modifying the F9 gene in human mesenchymal cells, aiming to enhance the production of Factor IX, a crucial protein for blood clotting. This work has potential therapeutic applications, particularly in treating hemophilia. His academic training has provided him with expertise in molecular biology, genetic engineering, and biomedical research. His strong foundation in experimental design and genetic modifications has positioned him as a key researcher in the field of gene therapy and molecular medicine.

Professional Experience

Dr. Lara Navarro has gained extensive professional experience in research and academia. From 2020 to 2021, he worked as a Research Technician at the Mexican Institute of Social Security (IMSS), contributing to nucleic acid extraction and molecular diagnostics in epidemiological surveillance. He later joined Laboratorio Biodiagnóstica in 2021, where he worked as a Molecular Biology Laboratory Technician, managing laboratory operations, coordinating research teams, and implementing molecular analysis techniques. In addition to his laboratory roles, he has been actively involved in teaching. He served as an Adjunct Professor at Tecmilenio University (Zapopan) from 2021 to 2022, teaching basic sciences at the high school level. Since 2023, he has been a faculty member at Universidad Guadalajara Lamar, where he teaches genetics and biomolecular sciences to medical students. His combined experience in laboratory research and academia has strengthened his ability to contribute to both scientific discovery and education.

Research Interests

Dr. Lara Navarro’s primary research interests lie in genetic engineering, molecular biology, and gene therapy. His doctoral research on CRISPR/Cas9-based gene modification for Factor IX production highlights his focus on therapeutic applications of molecular genetics. He is particularly interested in genetic therapies for hematological disorders, biotechnology applications in medicine, and the development of precision medicine approaches. His expertise in nucleic acid manipulation and viral vector systems contributes to advancements in personalized genetic treatments. Additionally, he has a keen interest in molecular diagnostics and epidemiological surveillance, particularly in developing genetic testing methodologies for disease prevention and treatment. As a researcher, he aims to explore the potential of stem cell therapy, regenerative medicine, and CRISPR-based genome editing for clinical applications. His work aims to bridge the gap between fundamental genetic research and practical medical solutions, contributing to cutting-edge advancements in biomedical sciences.

Awards and Honors

While Dr. Lara Navarro has demonstrated exceptional expertise in genetics and molecular biology, his professional journey is still evolving in terms of formal recognitions. His research in CRISPR/Cas9 gene therapy holds significant potential for future awards and funding opportunities. As an emerging scientist, he has been recognized for his contributions to molecular diagnostics and epidemiological research at IMSS, where he played a crucial role in laboratory procedures during the COVID-19 pandemic. His involvement in academia and research has earned him respect within the scientific and medical communities. While he may not yet have received high-profile research awards, his work on genetic modifications and biomedical applications positions him as a strong candidate for future honors in genetics, biotechnology, and medical research. With continued research output and publications, he is likely to receive formal recognition for his contributions to the field of genetic engineering and molecular medicine.

Conclusion

Dr. Irving Jair Lara Navarro has a strong foundation in genetics, molecular biology, and research methodologies, making him a promising candidate. However, to be a strong contender for the Best Researcher Award, he should focus on publishing in high-impact journals, securing research funding, and increasing international recognition. If these aspects are addressed, he would be a more competitive candidate for the award.

Publications Top Noted

  • CRISPR/Cas9 Edition of the F9 Gene in Human Mesenchymal Stem Cells for Hemophilia B Therapy
    • Authors: Lara-Navarro, I.J., Jave-Suárez, L.F., Marchal, J.A., Jaloma-Cruz, A.R.
    • Year: 2024
    • Journal: Life
    • Citations: 0
  • Current Therapies in Hemophilia: From Plasma-Derived Factor Modalities to CRISPR/Cas Alternatives
    • Authors: Lara-Navarro, I.J., Jaloma-Cruz, A.R.
    • Year: 2022
    • Journal: Tohoku Journal of Experimental Medicine
    • Citations: 3
  • Genetic analysis for carrier diagnosis in hemophilia A and B in the Mexican population: 25 years of experience
    • Authors: González-Ramos, I.-A., Mantilla-Capacho, J.-M., Luna-Záizar, H., Evangelista-Castro, N., Jaloma-Cruz, A.R.
    • Year: 2020
    • Journal: American Journal of Medical Genetics, Part C: Seminars in Medical Genetics
    • Citations: 5
  • Molecular thrombophilic profile in Mexican patients with idiopathic recurrent pregnancy loss
    • Authors: López-Jiménez, J.J., Porras-Dorantes, Á., Juárez-Vázquez, C.I., Lara-Navarro, I.J., Jaloma-Cruz, A.R.
    • Year: 2016
    • Journal: Genetics and Molecular Research
    • Citations: 19
  • Two girls with a de novo Xq rearrangement of paternal origin: T(X;9)(q24;q12) or rea(X)dup q
    • Authors: Vásquez-Velásquez, A.I., Rivera, H., Castro, A.G., Mendoza-Pérez, P., García-Ortiz, J.E.
    • Year: 2016
    • Journal: Taiwanese Journal of Obstetrics and Gynecology
    • Citations: 0
  • A further inv dup/del 9p de novo rearrangement. Reappraisal of 25 instances
    • Authors: Lara-Navarro, I.J., Córdova-Fletes, C., García-Ruiz, A., Rivera, H.
    • Year: 2015
    • Journal: Gene Reports
    • Citations: 0

 

Zhong Zhi | Genetics | Best Researcher Award

Dr. Zhong Zhi | Genetics | Best Researcher Award

Investigator, Inner Mongolia Agricultural University, China

Dr. Zhong Zhi 👨‍🔬 is an accomplished Investigator and Doctoral Supervisor specializing in lactic acid bacteria genomics and bioinformatics. He has published 30 papers in reputable academic journals, including Microbiome, Journal of Dairy Science, LWT – Food Science and Technology, and Food Microbiology. Among these, 15 are SCI-indexed papers, with a remarkable impact factor of 15.5 for his highest-cited work. Dr. Zhong has successfully led multiple national and provincial research projects, contributing significantly to the development and utilization of lactic acid bacteria resources. He was awarded the “Shennong Chinese Agricultural Science and Technology Award – Excellent Innovation Team Award” in 2017 and recognized for his excellent doctoral dissertation in 2019. 📚

Publication Profile.

Scopus

Education

Dr. Zhong Zhi holds a Ph.D. in a relevant field, showcasing a robust academic background that supports his extensive research endeavors in the realm of microbiology and food science. His educational journey has been pivotal in shaping his expertise in lactic acid bacteria and their applications.

Experience

With significant experience in research and academia, Dr. Zhong has presided over several national scientific research projects, including those funded by the National Natural Science Foundation of China. His role as a doctoral supervisor has allowed him to mentor and guide numerous students, fostering the next generation of scientists in microbiology and bioinformatics. His industrial and academic collaborations have enhanced the practical applications of his research.

Research Interests

Dr. Zhong’s primary research interests lie in lactic acid bacteria genomics and bioinformatics. He focuses on exploring the genetic characteristics and potential applications of these microorganisms in food science and technology. His work aims to harness the benefits of lactic acid bacteria in health and nutrition, addressing contemporary challenges in food safety and quality.

Awards

Dr. Zhong Zhi has received numerous accolades for his contributions to agricultural science and research innovation, including: 2017: Shennong Chinese Agricultural Science and Technology Award – Excellent Innovation Team Award (14th finisher) 🏆 2019: Excellent Doctoral Dissertation Award, Inner Mongolia Autonomous Region 🎓

Publications

Zhi Zhong†, Hai Tang†, Tingting Shen, Xinwei Ma, Feiyan Zhao, Lai Yu Kwok, Zhihong Sun, Menghe Bilige, Heping Zhang*. Bifdobacterium animalis subsp. lactis Probio-M8 undergoes host adaptive evolution by glcU mutation and translocates to the infant’s gut via oral-/entero-mammary routes through lactation. Microbiome, 2022. (IF: 16.837)

Hai Tang#, Zhi Zhong#, Jingqing Hou, Lijun You, Zhixin Zhao, Lai-Yu Kwok, Menghe Bilige*. Metagenomic analysis revealed the potential of lactic acid bacteria in improving natural saline-alkali land. International Microbiology, 2024.

Jingda Lu, Yue Jiao, Mengyuan Zhu, Yaru Sun, Lai-Yu Kwok, Zhi Zhong*. Fermented soy milk enhances survival and acid tolerance of Lactiplantibacillus plantarum LP-6 in an in vitro human stomach digestion system. LWT – Food Science and Technology, 2024.

Zhi Zhong, Tingting Shen, Jingda Lu, Xinwei Ma, Mengyuan Zhu, Lai-Yu Kwok, Wenjun Liu*. A genome-wide association study of antibiotic resistance in dairy products-associated Enterococcus faecium isolates. LWT – Food Science and Technology, 2023.

Jingda Lu, Tingting Shen, Yixin Zhang, Xinwei Ma, Sheng Xu, Sameh Awad, Muying Du, Zhi Zhong*. Safety assessment of Enterococcus lactis based on comparative genomics and phenotypic analysis. Frontiers in Microbiology, 2023.

maria livia ognean | Genetics | Best Researcher Award

Assoc. Prof. Dr.  maria livia ognean | Genetics | Best Researcher Award

Assoc. Prof., Lucian Blaga University Sibiu, Romania

Dr. Maria Livia Ognean , an accomplished neonatologist from Romania, is an Associate Professor at Universitatea Lucian Blaga din Sibiu and has been affiliated with the Clinical County Emergency Hospital Sibiu since 1994. Known for her expertise in neonatal intensive care (NICU), neonatal ultrasound, nursing, and nutrition, Dr. Ognean has greatly contributed to neonatal healthcare through her research and clinical work.

Publication Profile

scopus

Education

Dr. Ognean holds an MD and PhD in medicine from the Faculty of Medicine and Pharmacy in Tg. Mures 🎓. Her academic background has been pivotal in her work, supporting her specialized focus on neonatology and neonatal health.

Experience

With over two decades of experience, Dr. Ognean has been deeply involved in neonatology at the Clinical County Emergency Hospital Sibiu 🏥, where she has provided essential care to newborns in critical conditions. Since 2017, she has also served as an Associate Professor, imparting her knowledge to the next generation of medical professionals.

Research Focus

Dr. Ognean’s research primarily revolves around neonatology and neonatal care 💡. Her focus areas include NICU care, neonatal ultrasound, and neonatal nutrition, where she continuously works to improve outcomes for newborns. Her recent studies cover neonatal respiratory conditions, congenital infections, and innovative NICU practices.

Awards and Honours

Dr. Ognean has been recognized for her dedication to neonatology and healthcare advocacy 🏆. She currently serves as the Vice President of the Comisia Neonatologie a Ministerului Sanatatii and the Romanian Association of Neonatology, underscoring her leadership in the field.

Publication Top Notes

ABCA3 c.838C>T (p.Arg280Cys, R280C) and c.697C>T (p.Gln233Ter, Q233X, Q233) as Causative Variants for RDS: A Family Case Study and Literature Review*, published in Biomedicines, 2024, cited by articles on respiratory distress syndrome in neonates.

Effects of Prostaglandin E1 and Balloon Atrial Septostomy on Cerebral Blood Flow and Oxygenation in Newborns Diagnosed with Transposition of the Great Arteries, published in Biomedicines, 2024, cited for advancements in neonatal cardiac care.

Congenital Sepsis with Candida albicans—A Rare Event in the Neonatal Period: Report of Two Cases and Literature Review, published in Microorganisms, 2024, cited in studies of neonatal fungal infections.

Hamid Mukhtar | Biotechnology | Best Researcher Award

Prof Dr. Hamid Mukhtar | Biotechnology | Best Researcher Award

Professor & Director, Institute of Industrial Biotechnology, Government College University, Lahore, Pakistan

Hamid Mukhtar is a prominent researcher specializing in microbiology and biotechnology. With a strong focus on the biosynthesis of alkaline proteases and the utilization of endophytic fungi for taxol production, he has significantly contributed to advancements in the leather industry and pharmacology. His work exemplifies a commitment to innovative solutions in industrial biotechnology. 🎓

Publication Profile

Google Scholar

Education

Hamid Mukhtar earned his education in microbiology and biotechnology, laying a solid foundation for his extensive research career. His academic pursuits have driven him to explore various aspects of microbial applications in industries. 📚

Experience

With years of experience in the field, Hamid has worked on numerous research projects, including the establishment of a microbial culture bank and investigating chromium uptake by bacteria. His roles as a Co-PI in multiple projects showcase his collaborative spirit and leadership in research. 🔬

Research Focus

Hamid’s research primarily revolves around microbial biosynthesis, environmental microbiology, and the therapeutic potential of natural products. He is particularly interested in the applications of microbial enzymes and their implications in various industries, including pharmaceuticals and environmental science. 🧬

Awards and Honours

Hamid Mukhtar has received several prestigious awards for his contributions to research, including funding from the Higher Education Commission (HEC) and GCU Lahore. His recognition underscores his impact on the scientific community and industrial applications. 🏆

Publication Top Notes

Antimicrobial resistance: more than 70 years of war between humans and bacteria (Critical Reviews in Microbiology, 2020) Link

Relationship between method of anastomosis and anastomotic failure after right hemicolectomy and ileo‐caecal resection: an international snapshot audit (Colorectal Disease, 2017) Link

Podophyllotoxin: history, recent advances and future prospects (Biomolecules, 2021) Link

Bromelain: Methods of extraction, purification and therapeutic applications (Brazilian Archives of Biology and Technology, 2016) Link

Advances in valorization of lignocellulosic biomass towards energy generation Link

Ram Sagar | Genetics | Best Researcher Award

Dr. Ram Sagar | Genetics | Best Researcher Award

Postdoctoral Research fellow, Johns Hopkins University, United States

Dr. Ram Sagar is a distinguished researcher at the Department of Genetic Medicine, Johns Hopkins University, School of Medicine. With a robust background in neurology and clinical microbiology, Dr. Sagar specializes in the molecular mechanisms underlying Alzheimer’s disease and stroke. His work integrates advanced techniques in stem cell research and extracellular vesicle characterization to explore innovative treatment strategies. 🧬🧠

Publication Profile

Google Scholar

Strengths for the Award:

  • Extensive Research Experience: Dr. Ram Sagar has significant research experience in genetics, neurology, and neurobiology, with a particular focus on stroke and Alzheimer’s disease. His work at prestigious institutions like AIIMS, New Delhi, and Johns Hopkins University showcases his dedication and expertise.
  • Publications and Scientific Contributions: He has a strong publication record with articles in high-impact journals such as Molecular Psychiatry, Biomedicines, and Cells. His contributions include co-authored book chapters and research articles that explore innovative approaches to neurodegenerative disorders.
  • Technical Expertise: Dr. Sagar has developed advanced skills in various techniques, including RNA-Seq, lipidomics, 3D brain organoid modeling, and induced pluripotent stem cell (iPSC) technology. His diverse technical proficiency supports his multidisciplinary approach to neurobiology and precision medicine.
  • Awards and Recognitions: He has received several prestigious awards, including the Young Investigator Award by the World Stroke Congress and multiple international travel grants. These accolades highlight his recognition and credibility in the field.
  • Professional Involvement and Leadership: As an editorial board member and manuscript reviewer for several leading journals, Dr. Sagar demonstrates significant contributions to scientific communities. His involvement in various professional societies further reflects his leadership and commitment to advancing research in his field.

Areas for Improvement:

  • Funding and Grants: Although Dr. Sagar has received several travel grants, there is a limited mention of independently secured research funding or grants as a principal investigator. Securing independent funding is often a critical criterion for research excellence awards.
  • Collaborative Networks: Expanding collaborations with international researchers and institutions beyond his current affiliations could enhance his research impact and global recognition.
  • Longitudinal Research Studies: Engaging in or leading more extensive longitudinal studies could further solidify his contributions to the understanding of neurodegenerative diseases, which could strengthen his candidacy for the award.

Education

Dr. Sagar earned his Ph.D. in Neurology from AIIMS, New Delhi in 2019, with a focus on inflammatory gene polymorphisms and spontaneous intracerebral hemorrhage. He holds a Master’s degree in Clinical Microbiology from Punjab Technical University (2012) and a Bachelor’s degree in Zoology and Botany from Dr. RMLAU, Faizabad (2009). 🎓📚

Experience

Dr. Sagar has accumulated extensive research experience, including his current role as a Postdoctoral Research Fellow at Johns Hopkins University, where he investigates the role of extracellular vesicles in Alzheimer’s disease. Previously, he served as a Senior Research Officer and Junior Research Fellow at AIIMS, contributing to stroke biomarker research and genetic studies. 🧪🔬

Research Focus

Dr. Sagar’s research focuses on the clinical neurobiology of stroke and Alzheimer’s disease, utilizing human-induced pluripotent stem cells (hiPSCs) for disease modeling and drug testing. His interests include extracellular vesicle characterization, transcriptomic and lipidomic profiling, and precision medicine approaches. 🧬🔍

Awards and Honours

Dr. Sagar has been recognized for his outstanding contributions to neurobiology with awards such as the Young Investigator Award from the World Stroke Congress and multiple international travel grants for presenting his research at renowned conferences. 🏅🌍

Publication Top Notes

iPSC-derived hindbrain organoids to evaluate escitalopram oxalate treatment responses targeting neuropsychiatric symptoms in Alzheimer’s diseaseMolecular Psychiatry, 2024.

Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approachesJournal of Extracellular Vesicles, 2024.

Generation and Characterization of a Human-Derived and Induced Pluripotent Stem Cell (iPSC) Line from an Alzheimer’s Disease Patient with Neuropsychiatric SymptomsBiomedicines, 2023.

Excitatory neurons derived from human induced Pluripotent Stem Cells show transcriptomic differences in Alzheimer’s patients from controlsCells, 2023.

Association of SUMOlation Pathway Genes with Stroke in a Genome-wide Association Study in IndiaNeurology, 2021.

Conclusion:

Dr. Ram Sagar is a highly suitable candidate for the Research for Best Researcher Award due to his extensive research background, impressive publication record, diverse technical expertise, and numerous professional recognitions. His current work on Alzheimer’s disease using innovative methodologies like iPSC-derived neuronal differentiation and 3D brain organoids places him at the forefront of neurobiology research. However, securing more independent funding and expanding collaborative efforts could enhance his profile further. Overall, his strong academic, technical, and professional credentials make him a compelling nominee for the award.